(VIANEWS) – TPG Specialty Lending (TSLX), Reinsurance Group of America (RGA), Option Care Health (OPCH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. TPG Specialty Lending (TSLX)
51.1% sales growth and 8.26% return on equity
Sixth Street Specialty Lending, Inc. (NYSE: TSLX) is a business development company. The fund provides senior secured loans (first-lien, second-lien, and unitranche), unsecured loans, mezzanine debt, and investments in corporate bonds and equity securities and structured products, non-control structured equity, and common equity with a focus on co-investments for organic growth, acquisitions, market or product expansion, restructuring initiatives, recapitalizations, and refinancing. The fund invests in business services, software & technology, healthcare, energy, consumer & retail, manufacturing, industrials, royalty related businesses, education, and specialty finance. It seeks to finance and lending to middle market companies principally located in the United States. The fund invests in companies with enterprise value between $50 million and $1 billion or more and EBITDA between $10 million and $250 million. The transaction size is between $15 million and $350 million. The fund invests across the spectrum of the capital structure and can arrange syndicated transactions of up to $500 million and hold sizeable positions within its credits.
Earnings Per Share
As for profitability, TPG Specialty Lending has a trailing twelve months EPS of $1.38.
PE Ratio
TPG Specialty Lending has a trailing twelve months price to earnings ratio of 13.17. Meaning, the purchaser of the share is investing $13.17 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.26%.
2. Reinsurance Group of America (RGA)
10.7% sales growth and 7.27% return on equity
Reinsurance Group of America, Incorporated engages in reinsurance business. The company offers individual and group life and health insurance products, such as term life, credit life, universal life, whole life, group life and health, joint and last survivor insurance, critical illness, disability, and longevity products; asset-intensive and financial reinsurance products; and other capital motivated solutions. It also provides reinsurance for mortality, morbidity, lapse, and investment-related risk associated with products; and reinsurance for investment-related risks. In addition, the company develops and markets technology solutions; and provides consulting and outsourcing solutions for the insurance and reinsurance industries. It serves life insurance companies in the United States, Latin America, Canada, Europe, the Middle East, Africa, Australia, and the Asia Pacific. Reinsurance Group of America, Incorporated was founded in 1973 and is headquartered in Chesterfield, Missouri.
Earnings Per Share
As for profitability, Reinsurance Group of America has a trailing twelve months EPS of $9.07.
PE Ratio
Reinsurance Group of America has a trailing twelve months price to earnings ratio of 14.91. Meaning, the purchaser of the share is investing $14.91 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.27%.
Yearly Top and Bottom Value
Reinsurance Group of America’s stock is valued at $135.26 at 11:22 EST, way under its 52-week high of $153.35 and way above its 52-week low of $109.06.
Moving Average
Reinsurance Group of America’s value is below its 50-day moving average of $136.67 and below its 200-day moving average of $136.20.
Sales Growth
Reinsurance Group of America’s sales growth is 6.8% for the current quarter and 10.7% for the next.
3. Option Care Health (OPCH)
8.5% sales growth and 11.75% return on equity
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Earnings Per Share
As for profitability, Option Care Health has a trailing twelve months EPS of $0.82.
PE Ratio
Option Care Health has a trailing twelve months price to earnings ratio of 39.21. Meaning, the purchaser of the share is investing $39.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.75%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 5.9% and 15.8%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Option Care Health’s EBITDA is 67.72.
4. CBIZ (CBZ)
8% sales growth and 15.72% return on equity
CBIZ, Inc. provides financial, insurance, and advisory services in the United States and Canada. The company operates through three segments: Financial Services, Benefits and Insurance Services, and National Practices. The Financial Services segment offers accounting and tax, government healthcare consulting, financial advisory, valuation, and risk and advisory services. The Benefits and Insurance Services provides group health benefits consulting, payroll, property and casualty, and retirement plan services. The National Practices segment offers managed networking and hardware, and health care consulting services. It primarily serves small and medium-sized businesses, as well as individuals, governmental entities, and not-for-profit enterprises. The company was founded in 1987 and is headquartered in Cleveland, Ohio.
Earnings Per Share
As for profitability, CBIZ has a trailing twelve months EPS of $2.01.
PE Ratio
CBIZ has a trailing twelve months price to earnings ratio of 25.94. Meaning, the purchaser of the share is investing $25.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.72%.
